chr2-9374828-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003887.3(ASAP2):c.1630G>A(p.Ala544Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003887.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASAP2 | NM_003887.3 | c.1630G>A | p.Ala544Thr | missense_variant | 17/28 | ENST00000281419.8 | NP_003878.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASAP2 | ENST00000281419.8 | c.1630G>A | p.Ala544Thr | missense_variant | 17/28 | 1 | NM_003887.3 | ENSP00000281419 | P3 | |
ASAP2 | ENST00000315273.4 | c.1630G>A | p.Ala544Thr | missense_variant | 17/27 | 1 | ENSP00000316404 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251384Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135864
GnomAD4 exome AF: 0.0000376 AC: 55AN: 1461836Hom.: 0 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727216
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152200Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.1630G>A (p.A544T) alteration is located in exon 17 (coding exon 17) of the ASAP2 gene. This alteration results from a G to A substitution at nucleotide position 1630, causing the alanine (A) at amino acid position 544 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at